Gemmer Asset Management’s Fulgent Genetics FLGT Stock Holding History

Gemmer Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-187	Closed	-$11K	–	465
2022 Q1	$11K	Hold	187	–	–	﹤0.01%	663
2021 Q4	$19K	Buy	+187	New	+$16.4K	﹤0.01%	520
2021 Q2	–	Sell	-18	Closed	-$2K	–	1508
2021 Q1	$2K	Sell	18 -47	-72%	-$4.85K	﹤0.01%	1370
2020 Q4	$3K	Sell	65 -60	-48%	-$2.51K	﹤0.01%	1208
2020 Q3	$5K	Sell	125 -75	-38%	-$2.35K	﹤0.01%	858
2020 Q2	$3K	Sell	200 -200	-50%	-$3.06K	﹤0.01%	1038
2020 Q1	$4K	Buy	+400	New	+$5.57K	﹤0.01%	833

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gemmer Asset Management's FLGT Position: Q2 2022 in Review

Gemmer Asset Management sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 187 shares — an estimated $11K sold.

Gemmer Asset Management first reported a position in FLGT in Q1 2020 and held it in 7 quarters. The position peaked at $19K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

Gemmer Asset Management reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 187 Fulgent Genetics shares in Q2 2022, an estimated $11K.
Gemmer Asset Management first reported a position in Fulgent Genetics in Q1 2020 and held it in 7 quarters.
Gemmer Asset Management's Fulgent Genetics position peaked at $19K in Q4 2021.
262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.